Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
31.61 USD | +14.86% | +9.45% | -2.68% |
May. 28 | Sector Update: Health Care Stocks Retreat Tuesday Afternoon | MT |
May. 28 | Corcept Therapeutics Says Phase 3 Hypercortisolism Trial Meets Primary Endpoint; Shares Advance | MT |
Evolution of the average Target Price on Corcept Therapeutics Incorporated
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Corcept Therapeutics Incorporated
Truist Securities | |
HC Wainwright | |
Canaccord Genuity | |
SVB Securities LLC | |
Piper Sandler | |
Jefferies & Co. |
EPS Revisions
- Stock Market
- Equities
- CORT Stock
- Consensus Corcept Therapeutics Incorporated